13FGuru
Sign in with Google Sign in with Discord
Akre Capital Management avatar

Chuck Akre

Akre Capital Management

Akre Capital Management, the three-legged stool of business quality, people and reinvestment

Akre Capital is a focused quality-compounder manager. The central idea is the three-legged stool: exceptional business model, talented and honest management, and a long runway for reinvestment.

Sources Akre Capital Management official site SEC EDGAR profile Akre Capital profile Akre Focus Fund
Quality compounders CIK 1112520
2026-03-31 Latest 13F 17 Current holdings 44 Last 3 periods Change 2 Public materials
Latest 13F snapshot 2026-03-31 · 20 disclosed positions · $6.1B Top five 56.9%: MA, BN, KKR, MCO, V

Performance materials

  • Akre fund materials provide the best performance context. 13F filings help explain public equity positioning.

Firm and key people

  • Chuck Akre built the firm's framework around long-term compounding and business quality.
  • The public portfolio often shows a small set of durable compounders rather than constant trading.
  • Letters and public comments help explain why the firm holds companies through volatility.

Investment style

  • Look for high returns on capital, recurring economics, and reinvestment opportunities.
  • Management quality and capital allocation are as important as current valuation.
  • Long holding periods make thesis durability more important than quarterly noise.

Public materials

View timeline
Shareholder letters / memos 1
Interview 1
Public video 0
Public Q&A / speeches / presentations 0

Current holdings

13F period 2026-03-31 · Filed 2026-05-14
Stocks Shares Value Weight
MA 2,281,106 $1.1B 18.6%
BN 17,027,077 $689.1M 11.2%
KKR 6,718,078 $621.4M 10.1%
MCO 1,246,114 $543.6M 8.9%
V 1,638,798 $495.3M 8.1%
ROP 1,257,232 $444.9M 7.3%
CSGP 10,348,273 $417.4M 6.8%
FICO 363,765 $388.3M 6.3%
ORLY 3,885,813 $358.7M 5.8%
CPRT 7,998,938 $265.6M 4.3%
ABNB 2,034,473 $256.9M 4.2%
CCC 31,513,070 $189.1M 3.1%
CRM 717,799 $134.0M 2.2%
NOW 1,096,099 $114.6M 1.9%
GSHD 443,385 $18.9M 0.3%
SOPH 3,719,140 $18.4M 0.3%
AMT 50,772 $8.8M 0.1%

Last 3 quarters US 13F new / increased / reduced / sold-out positions

As of 13F 2026-03-31 · Filed 2026-05-14
Last 1 quarters Last 2 quarters Last 3 quarters Last 4 quarters
Stocks Action 13F period Current shares Previous shares Share change 13F value change
MA Major reduction 2026-03-31 Filed 2026-05-14 2,281,106 3,005,280 -24.1% -$575.9M
BN Major reduction 2026-03-31 Filed 2026-05-14 17,027,077 26,843,633 -36.6% -$542.8M
V Major reduction 2026-03-31 Filed 2026-05-14 1,638,798 2,676,628 -38.8% -$443.4M
KKR Major reduction 2026-03-31 Filed 2026-05-14 6,718,078 8,106,049 -17.1% -$411.9M
MCO Major reduction 2026-03-31 Filed 2026-05-14 1,246,114 1,735,231 -28.2% -$342.8M
ORLY Major reduction 2026-03-31 Filed 2026-05-14 3,885,813 6,719,819 -42.2% -$254.2M
CSGP Minor increase 2026-03-31 Filed 2026-05-14 10,348,273 9,617,805 7.6% -$229.3M
ABNB Major reduction 2026-03-31 Filed 2026-05-14 2,034,473 3,473,243 -41.4% -$214.5M
CRM New 2026-03-31 Filed 2026-05-14 717,799 0 - +$134.0M
NOW New 2026-03-31 Filed 2026-05-14 1,096,099 0 - +$114.6M
FICO Major increase 2026-03-31 Filed 2026-05-14 363,765 277,445 31.1% -$80.7M
ROP Minor increase 2026-03-31 Filed 2026-05-14 1,257,232 1,105,153 13.8% -$47.1M
CPRT Minor increase 2026-03-31 Filed 2026-05-14 7,998,938 7,867,967 1.7% -$42.5M
AMT Major reduction 2026-03-31 Filed 2026-05-14 50,772 255,267 -80.1% -$36.1M
DHR Sold out 2026-03-31 Filed 2026-05-14 0 69,516 -100.0% -$15.9M
GSHD Major increase 2026-03-31 Filed 2026-05-14 443,385 371,096 19.5% -$8.4M
CCC Major increase 2026-03-31 Filed 2026-05-14 31,513,070 24,836,984 26.9% -$8.4M
ORLY Major reduction 2025-12-31 Filed 2026-02-13 6,719,819 8,612,428 -22.0% -$315.6M
DHR Major reduction 2025-12-31 Filed 2026-02-13 69,516 874,831 -92.1% -$157.5M
CSGP Minor increase 2025-12-31 Filed 2026-02-13 9,617,805 9,306,485 3.3% -$138.5M
MCO Major reduction 2025-12-31 Filed 2026-02-13 1,735,231 2,118,949 -18.1% -$123.2M
CPRT Major increase 2025-12-31 Filed 2026-02-13 7,867,967 4,236,760 85.7% +$117.5M
KKR Minor reduction 2025-12-31 Filed 2026-02-13 8,106,049 8,713,264 -7.0% -$98.9M
BN Major increase 2025-12-31 Filed 2026-02-13 26,843,633 19,215,941 39.7% -$86.0M
ROP Minor reduction 2025-12-31 Filed 2026-02-13 1,105,153 1,156,673 -4.5% -$84.9M
MA Minor reduction 2025-12-31 Filed 2026-02-13 3,005,280 3,155,594 -4.8% -$79.3M
FICO Minor increase 2025-12-31 Filed 2026-02-13 277,445 260,849 6.4% +$78.7M
V Minor reduction 2025-12-31 Filed 2026-02-13 2,676,628 2,973,760 -10.0% -$76.5M
CCC Major increase 2025-12-31 Filed 2026-02-13 24,836,984 16,270,128 52.7% +$49.2M
AMT Major reduction 2025-12-31 Filed 2026-02-13 255,267 442,843 -42.4% -$40.4M
GSHD Minor increase 2025-12-31 Filed 2026-02-13 371,096 366,125 1.4% +$84,198
FICO Major increase 2025-09-30 Filed 2025-11-13 260,849 9,148 2751.4% +$373.6M
ROP Major reduction 2025-09-30 Filed 2025-11-13 1,156,673 1,439,468 -19.6% -$239.1M
DHR Major reduction 2025-09-30 Filed 2025-11-13 874,831 1,775,400 -50.7% -$177.3M
MCO Minor reduction 2025-09-30 Filed 2025-11-13 2,118,949 2,305,424 -8.1% -$146.7M
CPRT Major increase 2025-09-30 Filed 2025-11-13 4,236,760 1,200,000 253.1% +$131.6M
BN Minor reduction 2025-09-30 Filed 2025-11-13 19,215,941 19,219,290 -0.0% +$129.1M
AMT Major reduction 2025-09-30 Filed 2025-11-13 442,843 915,249 -51.6% -$117.1M
V Minor reduction 2025-09-30 Filed 2025-11-13 2,973,760 3,175,240 -6.3% -$112.2M
ORLY Minor reduction 2025-09-30 Filed 2025-11-13 8,612,428 9,410,714 -8.5% +$80.3M
MA Minor reduction 2025-09-30 Filed 2025-11-13 3,155,594 3,295,286 -4.2% -$56.8M
KKR Minor reduction 2025-09-30 Filed 2025-11-13 8,713,264 8,847,564 -1.5% -$44.7M
CSGP Minor reduction 2025-09-30 Filed 2025-11-13 9,306,485 9,309,232 -0.0% +$36.7M
CCC Minor increase 2025-09-30 Filed 2025-11-13 16,270,128 14,770,128 10.2% +$9.2M

Public video / Interview / Shareholder letter / Public Q&A

2 reliable public materials
Shareholder letter / fund letter

Akre Focus Fund Annual Report

The Akre Funds official profile page provides Akre Focus Fund annual reports, semi-annual reports and shareholder materials and is the primary public source for tracking Chuck Akre's quality compounding framework.

  • Akre's public profile generally revolves around the compounding machine, management, reinvestment capabilities, and valuation discipline.
  • The fund report is suitable for explaining why the portfolio has long-term concentration in payments, ratings, software and high capital return businesses.
  • Fund reporting and 13F need to be distinguished: the report explains the strategy, and the 13F shows U.S. discloseable holdings.
  • The official information page is more reliable than third-party articles, and it is also convenient for continuous tracking of fund reports.
  • This information can also help the average investor understand Akre's three-legged framework: business quality, talent, and reinvestment.
Interview Classic

Jean-Marie Eveillard on Global Value Investing

Eveillard's public interview discussing global value investing, capital preservation, cash, and avoiding permanent loss is an important source for understanding First Eagle's traditional value framework.

  • Eveillard's framework emphasizes capital preservation, unlike more aggressive deep value or growth strategies.
  • His emphasis on margins of safety, cash, and the avoidance of permanent losses lends itself to explaining First Eagle's defensive style.
  • Information helps investors understand that global value investing is not just about U.S. stocks, but also includes gold, overseas companies, and currency risks.
  • The interview can be used as a classic figure, because Eveillard is an important representative of modern global value investing.
  • This type of legacy material needs to be viewed as a source of framework rather than current trading views.